cycloserine has been researched along with Tuberculosis, Drug-Resistant in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (4.76) | 18.7374 |
1990's | 6 (9.52) | 18.2507 |
2000's | 14 (22.22) | 29.6817 |
2010's | 30 (47.62) | 24.3611 |
2020's | 10 (15.87) | 2.80 |
Authors | Studies |
---|---|
Moreno-Viguri, E; Pérez-Silanes, S; Santivañez-Veliz, M; Torres, E | 1 |
Arora, PR; Ashavaid, TF; Blum, AJ; Gajjar, I; Gupta, A; Gupte, N; Karane, M; Kharat, N; Mullerpattan, JB; Pinto, LM; Rodrigues, C; Sawant, N; Sharma, S; Shivakumar, SVBY; Tornheim, JA; Udwadia, ZF | 1 |
Guo, Y; Liu, H; Sha, W; Shen, H; Shen, X; Tan, G; Wu, X; Wu, Z; Yang, J; Yu, F | 1 |
Dong, L; Huang, H; Qin, S; Ren, R; Wang, F; Wen, S; Xiao, H; Xue, Y; Yu, X; Zhang, T | 1 |
Li, S; Pang, Y; Ren, W; Shang, Y; Wang, W; Wang, Y; Wu, X; Xue, Z | 1 |
André, P; Briki, M; Buclin, T; Burger, R; Choong, E; Cruchon, S; Da Silva Pereira Clara, JA; Decosterd, LA; Desfontaine, V; Kajkus, A; Koehler, N; Lange, C; Mazza-Stalder, J; Mercier, T; Opota, O; Sanchez Carballo, PM; Suttels, V | 1 |
Madaan, P; Sahu, JK; Saini, L; Singanamala, B; Singh, P; Vaidya, PC | 1 |
Intini, E; Kishore, G; Richeldi, L; Udwadia, ZF | 1 |
Cho, HJ; Kang, MW; Kim, J; Koh, WJ; Lim, YJ; Song, CH | 1 |
Jain, AK; Sharma, P | 1 |
E R, V; Keny, S; Lawande, D; Parrikar, A | 1 |
Becker, P; Keddy, KH; Lancaster, J; Shean, K; van der Walt, ML | 1 |
Centner, CM; Chirehwa, M; Court, R; de Vries, N; Denti, P; Gumbo, T; Harding, J; Maartens, G; McIlleron, H; Wiesner, L | 1 |
Jo, KW; Kim, WS; Lee, SD; Park, S; Shim, TS | 1 |
Alffenaar, JWC; Migliori, GB; Peloquin, CA | 1 |
Court, R; de Vries, N; Gumbo, T; Harding, J; Maartens, G; McIlleron, H; Stewart, A; Wiesner, L | 1 |
Bao, ZJ; Ding, SP; Fan, YM; Wu, LM; Xia, Q; Zhen, LB; Zhu, M | 1 |
Hemanth Kumar, AK; Polisetty, AK; Ramachandran, G; Sudha, V; Vijayakumar, A | 1 |
Chhabra, M; Jangra, MS | 1 |
Chu, NH; Fu, L; Guo, SC; Liu, ZQ; Lu, Y; Wang, B; Zhu, H | 1 |
Alffenaar, JC; Banu, S; Chapagain, ML; Deshpande, D; Dheda, K; Foongladda, S; Gumbo, T; Heysell, SK; Houpt, ER; Koeuth, T; Köser, CU; Lee, PS; McIlleron, H; Mpagama, SG; Ogarkov, O; Pholwat, S; Schön, T; Simbar, N; Sturkenboom, MGG | 1 |
Ahmed, S; Al-Shaer, MH; Alghamdi, WA; Alkabab, Y; Alsultan, A; An, G; Banu, S; Barbakadze, K; Cegielski, JP; Heysell, SK; Houpt, E; Kempker, RR; Kipiani, M; Mikiashvili, L; Peloquin, CA; Schmidt, S | 1 |
Khalid, UK; Kumar Verma, A; Mathuria, KK; Munjal, S; Myneedu, VP; Puri, MM; Sarin, R; Singla, N; Singla, R; Vohra, V | 1 |
Ramachandran, G | 1 |
Mugabo, P; Mulubwa, M | 1 |
Davis, JG; Farley, J; Lancaster, J; Odendaal, R; Shean, K; Van der Walt, M | 1 |
Hwang, TJ; Jafarov, A; Jakubowiak, W; Keshavjee, S; Nunn, P; Wares, DF | 1 |
Gratz, J; Heysell, SK; Houpt, ER; Kibiki, GS; Kumburu, H; Mpagama, SG; Ndusilo, N; Peloquin, CA; Stroup, S | 1 |
Kalmataeva, Z; Kurakpaev, K; Maimakov, T; Sadykova, L; Šmigelskas, K | 1 |
Behera, C; Krishna, K; Singh, HR | 1 |
Bai, KJ; Chang, CC; Chang, JH; Chiang, CY; Chiang, YC; Chuang, HC; Hung, WY; Yu, MC | 1 |
Bharti, H; Bhushan, B; Chander, R; Gupta, A; Kajal, NC; Ranga, V | 1 |
Ghim, JR; Kim, DH; Kim, JH; Lee, HK; Lee, SH; Lee, YM; Seo, KA; Shin, C; Shin, JG | 1 |
Hosmane, GB; Jain, A; Kushwaha, RA; Prasad, R; Singh, A; Srivastava, R | 1 |
Karak, A; Mukhopadhay, S; Paul, R; Santra, G | 1 |
Adebola, SO; Adedeji, TO; Adefuye, BO; Oladeji, SM; Sogebi, OA | 1 |
Li, C; Li, GL; Li, SJ; Lou, YL; Luo, Q; Lyu, JX; Wan, KL; Wang, RB | 1 |
Kirtaeva, OV; Lazareva, IaV; Sokolova, GB; Tsybanev, AA | 1 |
Kirtaeva, OV; Lazareva, IaR; Romanova, EV; Sokolova, GB; Tsybane, AA | 1 |
Desai, VB; Fredrick, JS; Joseph, P; Mohan, NS; Ramachandran, R; Raman, B; Thomas, A; Wares, F | 1 |
Andries, K; Bantubani, N; De Marez, T; Diacon, AH; Donald, PR; Grobusch, M; Lounis, N; Mahanyele, R; McNeeley, DF; Meyvisch, P; Narasimooloo, R; Patientia, RF; Pym, A; van Heeswijk, R | 1 |
Hassan, G; Kant, S; Parengal, J; Saheer, S | 1 |
Chen, TP; Chen, YH; Hwang, KP; Lee, YW; Lu, PL; Peng, CF; Tsai, JJ | 1 |
ALSTON, JM; CRAIG, JW; WILLIAMS, H | 1 |
BLALOCK, FA; CORPE, RF; GOLDHAMMER, EJ; GROSS, JH | 1 |
ALLISON, RF; INGLIS, RM; SCHLESS, JM; TOPPERMAN, S; WHITE, EF | 1 |
Han, L; Lee, DH; Lee, WC; Mitnick, CD; Park, SK; Seung, KJ | 1 |
Acha, J; Castillo, H; Guerra, D; Shin, S; Smith Fawzi, MC; Sweetland, A; Vega, P | 1 |
Kam, KM; Yip, CW | 1 |
Abbate, E; Ambroggi, M; Brea, A; De Lucas, M; Fulgenzi, A; Gonzalez, C; Martínez, D; Mosca, C; Musella, R; Natiello, M; Palmero, DJ | 1 |
Hoeppner, VH; Jones, W; Marciniuk, DD; Ward, HA | 1 |
Avramopoulos, I; Falagas, ME; Rafailidis, PI; Sapkas, G | 1 |
Farnia, P; Khoshnood, K; Mansoori, SD; Masjedi, H; Masjedi, MR; Mirsaeidi, SM; Mohammadi, F; Pooramiri, MV; Rowhani-Rahbar, A; Tabarsi, P; Velayati, AA; Zahirifard, S | 1 |
Ano, H; Danno, K; Han, Y; Kawahara, K; Matsumoto, T; Nagai, T; Takashima, T; Tamura, Y; Tsuyuguchi, I; Yoshida, H | 1 |
Barrera, L; de Kantor, IN | 1 |
Fujita, J; Hayashi, H; Hayashihara, K; Saito, T; Sunada, K | 1 |
Dhingra, VK; Hanif, M; Mittal, A; Rajpal, S | 1 |
Mühlberger, F; Nasbimana, J; Nturanye, F; Portaels, F | 1 |
Chau, CH; Lee, J; Wong, CF; Wong, PC; Yew, WW | 1 |
Berning, SE; Peloquin, CA | 1 |
Akula, SK; Anderson, DS; Aruna, AS; Johnson, JE | 1 |
Kuś, J; Michałowska-Mitczuk, D | 1 |
Musser, JM; Ramaswamy, S | 1 |
4 review(s) available for cycloserine and Tuberculosis, Drug-Resistant
Article | Year |
---|---|
d-Cycloserine Pharmacokinetics/Pharmacodynamics, Susceptibility, and Dosing Implications in Multidrug-resistant Tuberculosis: A Faustian Deal.
Topics: Antitubercular Agents; Cycloserine; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2018 |
Pharmacokinetics of Second-Line Anti-Tubercular Drugs.
Topics: Aminoglycosides; Aminosalicylic Acid; Antitubercular Agents; Child; Cycloserine; Ethionamide; Fluoroquinolones; Humans; Tuberculosis, Multidrug-Resistant | 2019 |
Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis.
Topics: Antibiotics, Antitubercular; Central Nervous System Diseases; Cycloserine; Humans; Isoxazoles; Mental Disorders; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2013 |
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cycloserine; Drug Resistance, Multiple; Ethambutol; Ethionamide; Fluoroquinolones; Genes, Bacterial; Isoniazid; Mutation; Mycobacterium tuberculosis; Polymorphism, Genetic; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Virulence | 1998 |
5 trial(s) available for cycloserine and Tuberculosis, Drug-Resistant
Article | Year |
---|---|
[Russian cycloserine in complex therapy of drug resistant tuberculosis].
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Cycloserine; Female; Humans; Male; Middle Aged; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2008 |
[Rezonizat and cycloserine in complex therapy of drug resistant tuberculosis (comparative studies)].
Topics: Adult; Antibiotics, Antitubercular; Cycloserine; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Oxazolidinones; Tuberculosis, Multidrug-Resistant; Young Adult | 2008 |
Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India.
Topics: Adult; Antibiotics, Antitubercular; Communicable Disease Control; Cycloserine; Directly Observed Therapy; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Ethionamide; Female; Humans; India; Kanamycin; Male; Middle Aged; Ofloxacin; Prospective Studies; Pyrazinamide; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2011 |
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.
Topics: Antitubercular Agents; Clarithromycin; Cycloserine; Dapsone; Diarylquinolines; Erythromycin; Female; Humans; Isoxazoles; Male; Ofloxacin; Oxazolidinones; Quinolines; Tuberculosis, Multidrug-Resistant | 2012 |
Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran.
Topics: Adolescent; Adult; Aged; Amikacin; Antitubercular Agents; Cycloserine; Drug Therapy, Combination; Female; Humans; Iran; Isoniazid; Male; Middle Aged; Ofloxacin; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2005 |
54 other study(ies) available for cycloserine and Tuberculosis, Drug-Resistant
Article | Year |
---|---|
Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis.
Topics: Animals; Antitubercular Agents; Cell Line; Cyclic N-Oxides; Drug Resistance, Multiple, Bacterial; Latent Tuberculosis; Mice; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis, Multidrug-Resistant | 2016 |
Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis.
Topics: Antitubercular Agents; Cycloserine; Depression; Humans; Incidence; Tuberculosis, Multidrug-Resistant | 2022 |
Use of Whole-Genome Sequencing to Predict
Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Drug Resistance; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2022 |
Bone Penetration of Cycloserine in Osteoarticular Tuberculosis Patients of China.
Topics: Antitubercular Agents; China; Cycloserine; Humans; Tuberculosis, Multidrug-Resistant; Tuberculosis, Osteoarticular | 2022 |
Minimum inhibitory concentration of cycloserine against Mycobacterium tuberculosis using the MGIT 960 system and a proposed critical concentration.
Topics: Antitubercular Agents; Cycloserine; Humans; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2022 |
A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis.
Topics: Antitubercular Agents; Cycloserine; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Isotopes; Mycobacterium tuberculosis; Tandem Mass Spectrometry; Tuberculosis, Multidrug-Resistant | 2022 |
Antitubercular therapy-induced psychosis.
Topics: Antitubercular Agents; Child; Cycloserine; Drug Therapy, Combination; Female; Humans; Psychoses, Substance-Induced; Tuberculosis, Multidrug-Resistant | 2019 |
Neuropsychiatric reactions induced by cycloserine in the treatment of multidrug-resistant tuberculosis: what an Indian female patient tells us.
Topics: Antitubercular Agents; Cycloserine; Depression; Female; Humans; India; Middle Aged; Suicide, Attempted; Tuberculosis, Multidrug-Resistant | 2019 |
Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Cycloserine; Extensively Drug-Resistant Tuberculosis; Female; Humans; Lung; Macrophage Activation; Macrophages; Male; Middle Aged; Mycobacterium tuberculosis; Prothionamide; Pyrazinamide; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2020 |
Ethionamide induced blue vision (cyanopsia): Case report.
Topics: Aminosalicylic Acid; Antitubercular Agents; Color Vision Defects; Cycloserine; Ethionamide; Female; Humans; Kanamycin; Linezolid; Moxifloxacin; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Gitelman-like syndrome: A rare complication of using aminoglycosides in tuberculosis - A case report.
Topics: Alkalosis; Antitubercular Agents; Capreomycin; Clofazimine; Cycloserine; Deprescriptions; Ethionamide; Gitelman Syndrome; Humans; Hypocalcemia; Hypokalemia; Levofloxacin; Linezolid; Male; Middle Aged; Pyrazinamide; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Water-Electrolyte Imbalance | 2020 |
Treatment Outcomes and Adverse Drug Effects of Ethambutol, Cycloserine, and Terizidone for the Treatment of Multidrug-Resistant Tuberculosis in South Africa.
Topics: Adult; Antitubercular Agents; Cycloserine; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Isoxazoles; Oxazolidinones; Pharmaceutical Preparations; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2020 |
Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Cycloserine; Depression; Female; HIV Infections; Humans; Incidence; Isoxazoles; Male; Middle Aged; Oxazolidinones; Peripheral Nervous System Diseases; Prospective Studies; Psychoses, Substance-Induced; Risk Factors; Tuberculosis, Multidrug-Resistant | 2021 |
Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis.
Topics: Adult; Age Distribution; Aged; Alcohol Drinking; Aminosalicylic Acid; Antitubercular Agents; Cohort Studies; Comorbidity; Cycloserine; Ethambutol; Female; Fluoroquinolones; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Prothionamide; Pyrazinamide; Republic of Korea; Retrospective Studies; Rifampin; Severity of Illness Index; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Making optimal use of available anti-tuberculosis drugs: first steps to investigate terizidone.
Topics: Antitubercular Agents; Cycloserine; Humans; Isoxazoles; Oxazolidinones; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2018 |
Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; Area Under Curve; Chromatography, Liquid; Cycloserine; Female; HIV Infections; Humans; Isoxazoles; Male; Middle Aged; Oxazolidinones; Prospective Studies; Regression Analysis; South Africa; Tandem Mass Spectrometry; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
Prognostic factors for treatment success in patients with multidrug-resistant tuberculosis in China.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acid; Antitubercular Agents; Child; China; Cycloserine; Drug Administration Schedule; Female; Hemoglobins; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Retrospective Studies; Thyrotropin; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Urinalysis; Young Adult | 2018 |
A selective and sensitive high performance liquid chromatography assay for the determination of cycloserine in human plasma.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Cycloserine; Humans; Reproducibility of Results; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
Cycloserine Induced Suicidal Tendencies and Kanamycin Induced Ototoxicity in Indian MDR-TB Patient: A Case Report.
Topics: Antitubercular Agents; Cycloserine; Drug Therapy, Combination; Hearing Disorders; Humans; India; Kanamycin; Male; Middle Aged; Suicidal Ideation; Tuberculosis, Multidrug-Resistant | 2018 |
Therapeutic drug monitoring of cycloserine and linezolid during anti-tuberculosis treatment in Beijing, China.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Beijing; Chromatography, High Pressure Liquid; Cycloserine; Drug Monitoring; Female; Humans; Linezolid; Logistic Models; Male; Middle Aged; Retrospective Studies; Tandem Mass Spectrometry; Tuberculosis, Multidrug-Resistant; Young Adult | 2018 |
Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis.
Topics: Anti-Bacterial Agents; Cycloserine; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2019 |
Initial experience of bedaquiline implementation under the National TB Programme at NITRD, Delhi, India.
Topics: Adult; Antitubercular Agents; Cardiotoxicity; Clofazimine; Cycloserine; Diarylquinolines; Drug Therapy, Combination; Electrocardiography; Ethionamide; Female; Humans; India; Linezolid; Male; Moxifloxacin; National Health Programs; Sputum; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2019 |
Sensitive Ultra-performance Liquid Chromatography Tandem Mass Spectrometry Method for Determination of Cycloserine in Plasma for a Pharmacokinetics Study.
Topics: Antibiotics, Antitubercular; Chromatography, High Pressure Liquid; Cycloserine; Humans; Limit of Detection; Linear Models; Reproducibility of Results; Tandem Mass Spectrometry; Tuberculosis, Multidrug-Resistant | 2019 |
Serious treatment related adverse drug reactions amongst anti-retroviral naïve MDR-TB patients.
Topics: Adult; Antitubercular Agents; Coinfection; Cycloserine; Drug Resistance, Multiple, Bacterial; Female; Hearing Loss; HIV Infections; Humans; Isoxazoles; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Prospective Studies; Psychoses, Substance-Induced; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis.
Topics: Adolescent; Adult; Amikacin; Antitubercular Agents; Cycloserine; Ethionamide; Female; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Sputum; Tanzania; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
Treatment of tuberculosis in South Kazakhstan: clinical and economical aspects.
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Capreomycin; Cycloserine; Drug Costs; Female; Humans; Kazakhstan; Male; Middle Aged; Ofloxacin; Prothionamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
Antitubercular drug-induced violent suicide of a hospitalised patient.
Topics: Antitubercular Agents; Cycloserine; Drug Therapy, Combination; Ethambutol; Heart Injuries; Hospitalization; Humans; India; Levofloxacin; Male; Psychoses, Substance-Induced; Self-Injurious Behavior; Suicide; Tuberculosis, Multidrug-Resistant; Violence; Wounds, Stab; Young Adult | 2014 |
Serum concentrations of cycloserine and outcome of multidrug-resistant tuberculosis in Northern Taiwan.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Cycloserine; Drug Administration Schedule; Drug Monitoring; Female; Humans; Intestinal Absorption; Male; Middle Aged; Taiwan; Tertiary Care Centers; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
Profile of adverse drug reactions in drug resistant tuberculosis from Punjab.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Arthralgia; Ataxia; Chemical and Drug Induced Liver Injury; Child; Cycloserine; Drug Eruptions; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Gastrointestinal Diseases; Hearing Loss; Humans; Hypothyroidism; India; Kanamycin; Levofloxacin; Male; Middle Aged; Peripheral Nervous System Diseases; Psychoses, Substance-Induced; Pyrazinamide; Severity of Illness Index; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vision Disorders; Young Adult | 2014 |
Low Serum Concentrations of Moxifloxacin, Prothionamide, and Cycloserine on Sputum Conversion in Multi-Drug Resistant TB.
Topics: Adult; Aged; Antitubercular Agents; Chromatography, High Pressure Liquid; Cycloserine; Fluoroquinolones; Humans; Medication Adherence; Middle Aged; Moxifloxacin; Prothionamide; Retrospective Studies; Sputum; Tandem Mass Spectrometry; Tuberculosis, Multidrug-Resistant; Young Adult | 2015 |
Frequency of adverse events observed with second-line drugs among patients treated for multidrug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; Cohort Studies; Cycloserine; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Humans; Kanamycin; Male; Ofloxacin; Pyrazinamide; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
Gitelman-like Syndrome with Kanamycin Toxicity.
Topics: Adult; Alkalosis; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Ethionamide; Female; Fluoroquinolones; Humans; Hypokalemia; Kanamycin; Moxifloxacin; Muscle Cramp; Potassium; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2016 |
Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy.
Topics: Adult; Age Factors; Aminoglycosides; Antitubercular Agents; Audiometry, Pure-Tone; Body Mass Index; Coinfection; Comorbidity; Cycloserine; Diabetes Mellitus; Female; Hearing Loss; HIV Infections; Humans; Kanamycin; Levofloxacin; Male; Middle Aged; Nigeria; Prospective Studies; Prothionamide; Pyrazinamide; Risk Factors; Time Factors; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
[A preliminary study on the molecular characteristics of D-cycloserine resistance of
Topics: Antibiotics, Antitubercular; Beijing; Cycloserine; Genotype; Humans; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2017 |
Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient.
Topics: Adult; Antitubercular Agents; Clarithromycin; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; HIV Seronegativity; Humans; Isoniazid; Kanamycin; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2012 |
The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000.
Topics: Antitubercular Agents; Cycloserine; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Taiwan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
Cycloserine treatment of out-patients with chronic drug resistant pulmonary tuberculosis.
Topics: Cycloserine; Outpatients; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1961 |
RE-TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS AT BATTEY STATE HOSPITAL.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethambutol; Ethionamide; Geriatrics; Hospitals, State; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Viomycin | 1964 |
THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS.
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethionamide; Hepatomegaly; Isoniazid; Kanamycin; Liver Function Tests; Pharmacology; Pyrazinamide; Toxicology; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Viomycin | 1965 |
Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acid; Antitubercular Agents; Cohort Studies; Cycloserine; Female; Humans; Kanamycin; Korea; Male; Middle Aged; Ofloxacin; Prothionamide; Pyrazinamide; Retrospective Studies; Self Administration; Streptomycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
Psychiatric issues in the management of patients with multidrug-resistant tuberculosis.
Topics: Adult; Age Distribution; Antibiotics, Antitubercular; Anxiety; Cycloserine; Depressive Disorder; Female; Humans; Incidence; Interview, Psychological; Male; Medical Records; Middle Aged; Mycobacterium tuberculosis; Peru; Psychoses, Substance-Induced; Tuberculosis, Multidrug-Resistant | 2004 |
Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
Topics: Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Communicable Disease Control; Cycloserine; Directly Observed Therapy; Drug Combinations; Ethionamide; Hong Kong; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Population Surveillance; Program Evaluation; Recurrence; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Argentina; Cycloserine; Drug Combinations; Ethionamide; Female; Follow-Up Studies; HIV Seronegativity; Hospitalization; Hospitals, Special; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prognosis; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
Treatment outcome of multidrug-resistant tuberculosis among Vietnamese immigrants.
Topics: Capreomycin; Cycloserine; Drug Therapy, Combination; Emigration and Immigration; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Ofloxacin; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Vietnam | 2005 |
Multidrug-resistant tuberculous spondylodiscitis: need for aggressive management and drug susceptibility testing of Mycobacterium tuberculosis isolates.
Topics: Anti-Bacterial Agents; Biopsy, Fine-Needle; Bone Transplantation; Cycloserine; Discitis; Drug Therapy, Combination; Ethambutol; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Streptomycin; Thoracic Vertebrae; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Osteoarticular; Vitamin B 6; Vitamin B Complex | 2006 |
[Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy].
Topics: Adult; Aminosalicylic Acid; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Cycloserine; Drug Resistance, Multiple; Ethambutol; Female; Humans; Mutation; Mycobacterium tuberculosis; Parturition; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyrazinamide; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2006 |
Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Argentina; Clinical Trials as Topic; Cycloserine; Drug Therapy, Combination; Ethionamide; Evidence-Based Medicine; Follow-Up Studies; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
[A case of multi-drug resistant tuberculosis showing psychiatric adverse effect by cycloserine].
Topics: Antibiotics, Antitubercular; Cycloserine; Humans; Male; Mental Disorders; Middle Aged; Seizures; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2008 |
Outcome of multi-drug resistant tuberculosis cases treated by individualized regimens at a tertiary level clinic.
Topics: Adolescent; Adult; Aminoglycosides; Aminosalicylic Acid; Antitubercular Agents; Child; Cycloserine; Ethambutol; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pyrazinamide; Radiography; Severity of Illness Index; Thioamides; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2008 |
[Ofloxacin-cycloserine-protionamide-INH combination against treatment refractory lung tuberculosis].
Topics: Adult; AIDS-Related Opportunistic Infections; Cycloserine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Ofloxacin; Prothionamide; Recurrence; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1995 |
Adverse neurological reactions in patients with multidrug-resistant pulmonary tuberculosis after coadministration of cycloserine and ofloxacin.
Topics: Adult; Cycloserine; Depression; Drug Therapy, Combination; Humans; Male; Middle Aged; Ofloxacin; Seizures; Sleep Initiation and Maintenance Disorders; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1993 |
Advice on treatment of drug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; Ciprofloxacin; Cycloserine; Drug Monitoring; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethionamide; Humans; Ofloxacin; Tuberculosis, Multidrug-Resistant | 1997 |
Cycloserine-induced Stevens-Johnson syndrome in an AIDS patient with multidrug-resistant tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Cycloserine; Drug Therapy, Combination; Exanthema; Fatal Outcome; Humans; Male; Stevens-Johnson Syndrome; Tuberculosis, Multidrug-Resistant | 1997 |
[Reasons for chronic expectoration--case reports].
Topics: Adult; Aged; Antitubercular Agents; Capreomycin; Cycloserine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Rifampin; Secondary Prevention; Sputum; Streptomycin; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |